Related Experiment Video
Updated: Dec 30, 2025
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-124 enhances cell radiosensitivity by targeting PDCD6 in nasopharyngeal carcinoma
Yuqin Zhang1, Lin Zheng2, Shuimiao Lin3
1Department of Radiation Oncology, The First Affiliated Hospital of Jinan University Guangzhou, Guangdong Province, China.
Background:
Radiation resistance poses a major clinical challenge in treatment of nasopharyngeal carcinoma (NPC). Studies have shown that the abnormal expression of microRNAs (miRNAs) is associated with radiosensitivity, however, the mechanisms have not been fully elucidated. The aim of this study, therefore, was to investigate whether ectopic expression of miR-124 is correlated with radiosensitivity in NPC.
Methods:
In this study, the expression level of miR-124 was evaluated in NPC cell lines and patient specimens using quantitative reverse transcription-PCR (Real-time qPCR). Cell radiosensitivity was determined by colony formation assay. Target prediction algorithms and luciferase assay were used to confirm the target of miR-124. Tumor xenograft model was performed to understand the functions of miR-124 in vivo.
Results:
We found that miR-124 was down-regulated in both NPC specimens and NPC cell lines. Ectopic expression of miR-124 increased radiosensitivity of NPC cells. In vivo assays extended the significance of these results, showing that miR-124 overexpression decreased cell resistance to radiation treatment in tumor xenografts. Furthermore, we identified PDCD6 as a novel direct target of miR-124. Functional studies showed that knockdown PDCD6 enhanced cell radosensitivity to irradiation, and PDCD6 could rescue the effect caused by overexpression of miR-124, indicating that PDCD6 is a functional target of miR-124.
Conclusions:
MiR-124 enhances cell radiosensitivity by targeting PDCD6, miR-124/PDCD6 axis may facilitate the development of novel targeted therapies for NPC.
Insights
MicroRNA-124 (miR-124) enhances radiosensitivity in nasopharyngeal carcinoma (NPC) by targeting PDCD6. This miR-124/PDCD6 interaction offers a potential new therapeutic strategy for NPC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Radiation resistance is a significant clinical challenge in nasopharyngeal carcinoma (NPC) treatment.
- MicroRNAs (miRNAs) are implicated in radiosensitivity, but underlying mechanisms require further elucidation.
- Investigating the role of miR-124 in NPC radiosensitivity is crucial for understanding treatment resistance.
Purpose of the Study:
- To determine the correlation between ectopic expression of miR-124 and radiosensitivity in NPC.
- To elucidate the molecular mechanisms by which miR-124 influences NPC radiosensitivity.
- To identify potential therapeutic targets for overcoming radiation resistance in NPC.
Main Methods:
- Quantitative reverse transcription-PCR (Real-time qPCR) to assess miR-124 expression in NPC cell lines and patient samples.
- Colony formation assays to evaluate the impact of miR-124 on NPC cell radiosensitivity.
- Bioinformatic target prediction, luciferase assays, and *in vivo* tumor xenograft models to confirm miR-124 targets and functions.
Main Results:
- miR-124 expression was found to be downregulated in NPC specimens and cell lines.
- Overexpression of miR-124 significantly increased NPC cell radiosensitivity, both *in vitro* and *in vivo*.
- PDCD6 was identified as a direct functional target of miR-124, mediating its radiosensitizing effects.
Conclusions:
- The miR-124/PDCD6 axis plays a critical role in enhancing NPC cell radiosensitivity.
- Targeting the miR-124/PDCD6 pathway presents a promising strategy for developing novel therapies for nasopharyngeal carcinoma.
- This finding could lead to improved treatment outcomes for patients with radiation-resistant NPC.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
